ZIOPHARM ONCOLOGY
Ziopharm Oncology is a biotechnology company employing a novel gene expression and control technology to deliver DNA for the treatment of cancer. ZIOPHARM's technology platform employs Intrexon Corporation's RheoSwitch Therapeutic System® to turn on and off and precisely modulate gene expression at the cancer site in order to improve the therapeutic index. This technology is currently being evaluated in Phase 2 clinical studies of the immune system cytokine interleukin-12 for the treatment of breast cancer and advanced melanoma. Multiple new INDs for new targets using similar technology are expected in 2014 and 2015. ZIOPHARM is also developing novel small molecules as potential cancer therapeutics.
ZIOPHARM ONCOLOGY
Industry:
Biotechnology Genetics Pharmaceutical Therapeutics
Founded:
2005-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.ziopharm.com
Total Employee:
11+
Status:
Active
Contact:
617-259-1970
Email Addresses:
[email protected]
Total Funding:
277.69 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Font Awesome Domain Not Resolving Microsoft Exchange Online Office 365 Mail IPv6 Microsoft Azure DNS GoDaddy DNS
Similar Organizations
Axcella
Axcella is a biotechnology company providing therapeutics development solutions.
Imvax
Imvax is a biotechnology company focused on the development of novel patient-specific vaccines and immunotherapy strategies.
Kairos BioMedical
Kairos BioMedical is a biomedical company that discovers, develops, and commercializes immuno preventative and therapeutic products.
Nutcracker Therapeutics
Nutcracker Therapeutics is a biotech company that develops mRNA therapeutics.
Translate Bio
Translate Bio is a biotechnology company that specializes in biotechnology, RNA therapeutics, and rare diseases.
Tango Therapeutics
Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Henderson Global Investors
Henderson Global Investors investment in Post-IPO Equity - Ziopharm oncology
Essex Woodlands Healthcare Partners
Essex Woodlands Healthcare Partners investment in Post-IPO Equity - Ziopharm oncology
ProQuest Investments
ProQuest Investments investment in Post-IPO Equity - Ziopharm oncology
Pinto Technology Ventures
Pinto Technology Ventures investment in Post-IPO Equity - Ziopharm oncology
LBI Group
LBI Group investment in Post-IPO Equity - Ziopharm oncology
ProQuest Investments
ProQuest Investments investment in Post-IPO Equity - Ziopharm oncology
Pangaea Asset Management
Pangaea Asset Management investment in Post-IPO Equity - Ziopharm oncology
Paramount BioCapital Asset Management
Paramount BioCapital Asset Management investment in Post-IPO Equity - Ziopharm oncology
LBI Group
LBI Group investment in Post-IPO Equity - Ziopharm oncology
Cycad Group
Cycad Group investment in Post-IPO Equity - Ziopharm oncology
Key Employee Changes
Official Site Inspections
http://www.ziopharm.com
- Host name: a2aa9ff50de748dbe.awsglobalaccelerator.com
- IP address: 15.197.148.33
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
